Lisata Therapeutics, Inc.
LSTA
$1.93
$0.031.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.04% | 10.19% | 3.72% | 4.10% | 3.38% |
| Total Depreciation and Amortization | -4.44% | -8.11% | -8.56% | -7.94% | -4.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.09% | 103.46% | 45.58% | 22.85% | -18.66% |
| Change in Net Operating Assets | -195.67% | 376.16% | -128.13% | -88.96% | 128.14% |
| Cash from Operations | 8.83% | 17.82% | 6.00% | 3.37% | 15.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 169.22% | -79.55% | 32.71% | 30.99% | -73.29% |
| Cash from Investing | 168.76% | -79.67% | 32.48% | 30.99% | -73.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,119.64% | 489.29% | -39.50% | -85.71% | -87.98% |
| Repurchase of Common Stock | -171.13% | -160.14% | -153.38% | -201.10% | -56.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 446.51% | 40.22% | -126.52% | -153.51% | -122.93% |
| Foreign Exchange rate Adjustments | 15.15% | 36.67% | 103.13% | -243.75% | -178.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.04% | -348.92% | 74.99% | 33.23% | -1,459.89% |